<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   International adoption: Immunization considerations
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       International adoption: Immunization considerations
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        International adoption: Immunization considerations
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mary Allen Staat, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Oct 18, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H476048120">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Each year thousands of children immigrate to the United States through international adoption. Internationally adopted children are at increased risk for common infectious diseases such as tuberculosis, intestinal parasites, skin infections, and infestations because they come from resource-poor countries where these conditions are common. Assuring that these children are protected against vaccine-preventable diseases often can be challenging. Many internationally adopted children have poor documentation of immunizations from their birth country or may not have had the opportunity to have received the vaccines routinely given in the United States.
        </p>
        <p>
         Immunization of internationally adopted children and their close contacts will be discussed here. Infectious diseases in international adoptees and general issues related to adoption are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16709.html" rel="external">
          "International adoption: Infectious disease aspects"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2854.html" rel="external">
          "Adoption"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H540328886">
         <span class="h1">
          IMMUNIZATIONS FOR INTERNATIONAL ADOPTEES
         </span>
        </p>
        <p class="headingAnchor" id="H540329761">
         <span class="h2">
          Immunizations in the country of origin
         </span>
         <span class="headingEndMark">
          —
         </span>
         Routine immunization schedules vary from country to country and are available for specific countries through the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fimmunizationdata.who.int%2Flisting.html%3Ftopic%3Dvaccine-schedule%26location%3D&amp;token=c1aMGh80n5JfqNiS4zUVhkGZJHzJhW7hYZJMwrVG0LFEFjNX7MxA62uBiY6p7F6hXgl8VfAnRnqUWG6LumPYIJJ9nBP597SAHqgFR7nC42s%3D&amp;TOPIC_ID=89453" target="_blank">
          World Health Organization
         </a>
         (WHO). Most children arrive to the United States with documentation of some immunizations from their birth country. Children often receive some immunizations during the exit evaluation in their country of origin.
        </p>
        <p>
         Internationally adopted children typically have had the opportunity to receive the following immunizations in their countries of origin  (
         <a class="graphic graphic_table graphicRef91326" href="/z/d/graphic/91326.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bacillus Calmette-Guérin
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diphtheria, tetanus, and pertussis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poliovirus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatitis B
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Measles (with or without mumps and rubella)
        </p>
        <p>
        </p>
        <p>
         Some countries may also immunize against
         <em>
          Haemophilus influenzae
         </em>
         type b (Hib). Increasingly, other vaccines such as pneumococcal conjugate, rotavirus, hepatitis A virus, influenza, and varicella vaccines are being administered to young children in the countries from which international adoption to the United States occur.
        </p>
        <p>
         Countries of origin may use vaccines that differ from those administered in the United States (eg, bivalent oral
         <a class="drug drug_pediatric" data-topicid="12967" href="/z/d/drug information/12967.html" rel="external">
          poliovirus vaccine
         </a>
         [OPV] rather than trivalent inactivated poliovirus vaccine [IPV]; whole-cell rather than acellular pertussis-containing vaccines; monovalent measles vaccine rather than combination measles, mumps, rubella vaccine, etc). They also may have different contraindications (eg, encephalopathy and congenital heart disease, which are contraindications to vaccination in China), which may contribute to lack of immunization [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The Immigration and Nationality Act of 2009 stipulates that anyone seeking residence in the United States must show proof of age-appropriate vaccination as recommended by the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fimmigrantrefugeehealth%2Flaws-regs%2Fvaccination-immigration%2Frevised-vaccination-immigration-faq.html&amp;token=rIBrS1R8iVgafZvIhyUhCo7GSg%2F3JwBSjeu82RCY0lzACffpkKJdmiSfUEVEu%2Bd1K3vQQlJ37H%2Ff9ezsgq0NW%2FXc%2Bkrb8YeEPKfKk1ryW1yLKugFXOEN19Hf6jWtCuRP&amp;TOPIC_ID=89453" target="_blank">
          Centers for Disease Control and Prevention
         </a>
         (CDC) Advisory Committee on Immunization Practices [
         <a href="#rid3">
          3,4
         </a>
         ]. However, parents of internationally adopted children younger than 10 years may obtain a waiver allowing them to receive the first dose of these vaccines within 30 days of their arrival to the United States.
        </p>
        <p class="headingAnchor" id="H540328900">
         <span class="h2">
          Immunization after adoption
         </span>
         <span class="headingEndMark">
          —
         </span>
         Internationally adopted children should be immunized according to the United States' recommended schedule for healthy infants, children, and adolescents  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ).
        </p>
        <p>
         It can be challenging for clinicians to determine which immunizations are necessary. Most international adoptees have some documentation of receipt of immunizations, but the documentation may not be complete or reliable [
         <a href="#rid5">
          5,6
         </a>
         ]. In addition, vaccine response may be suboptimal because of poor vaccine storage, inadequate vaccine intervals, or malnutrition [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         The approach to immunizing internationally adopted children depends upon the availability and quality of documentation of immunizations administered in the home country. Only written documentation should be accepted as evidence of previous immunization [
         <a href="#rid6">
          6,8-10
         </a>
         ].
        </p>
        <p>
         Documentation of a clinical diagnosis of measles, mumps, rubella, varicella, or hepatitis A from the child's country of origin should not be accepted as evidence of immunity [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H540328907">
         <span class="h3">
          Valid immunization record
         </span>
         <span class="headingEndMark">
          —
         </span>
         Written records may be considered valid if the vaccines, dates of administration, numbers of doses, intervals between doses, and age of the patient at the time of immunization are comparable to United States  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ) or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fimmunizationdata.who.int%2Flisting.html%3Ftopic%3Dvaccine-schedule%26location%3D&amp;token=c1aMGh80n5JfqNiS4zUVhkGZJHzJhW7hYZJMwrVG0LFEFjNX7MxA62uBiY6p7F6hXgl8VfAnRnqUWG6LumPYIJJ9nBP597SAHqgFR7nC42s%3D&amp;TOPIC_ID=89453" target="_blank">
          WHO
         </a>
         schedules [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For poliovirus immunization, this requires immunization with trivalent IPV or trivalent oral
         <a class="drug drug_pediatric" data-topicid="12967" href="/z/d/drug information/12967.html" rel="external">
          poliovirus vaccine
         </a>
         (tOPV); doses of OPV administered on or after April 1, 2016 should not be counted (they are presumed to be bivalent OPV or monovalent OPV) [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For hepatitis A immunization, this requires immunization with a vaccine other than Aimmugen or Twinrix Jr [
         <a href="#rid10">
          10
         </a>
         ]. Twinrix Jr is a combination hepatitis A/hepatitis B vaccine; the hepatitis B component can be counted as valid, but not the hepatitis A component because it contains less hepatitis A antigen than hepatitis A vaccinees used for children in the United States.
        </p>
        <p>
        </p>
        <p>
         A chart with the terms used for vaccine-preventable diseases in various languages is available through
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.immunize.org%2Fcatg.d%2Fp5122.pdf&amp;token=bJ98wEjwYbR6KcGnbD%2BLoU1ezzdWkZCorrIe%2ByNBPbVdmHGWXGjX9wseTc1uIzA0AmY7SFwa0Sxw8J%2Bc3e4wZg%3D%3D&amp;TOPIC_ID=89453" target="_blank">
          Immunize.org
         </a>
         .
        </p>
        <p>
         Children who have an adequate written immunization record for vaccines received in the home country but whose immunizations are not up-to-date should receive catch-up immunizations as appropriate for their age  (
         <a class="graphic graphic_table graphicRef58271 graphicRef72079" href="/z/d/graphic/58271.html" rel="external">
          table 2A-B
         </a>
         ).
        </p>
        <p>
         Several studies evaluating serologic testing to verify the immunization status or immune response to vaccine-preventable diseases in internationally adopted children have inconsistent findings [
         <a href="#rid5">
          5,13-25
         </a>
         ].
         <sup>
         </sup>
         Differences in study design and laboratory methods may account for the different results from these studies. In the largest study, international adoptees with documentation of ≥3 doses of diphtheria, tetanus, pertussis, poliovirus, hepatitis B, and Hib and, for children ≥12 months, ≥1 dose of measles, mumps, rubella, and varicella in their home country were more likely to have protective antibody than those without documentation, as illustrated below [
         <a href="#rid23">
          23
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diphtheria – 85 versus 69 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tetanus – 95 versus 76 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poliovirus – 93 versus 83 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hepatitis B – 77 versus 42 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hib – 67 versus 27 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Measles – 95 versus 58 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mumps – 72 versus 31 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rubella – 94 versus 30 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Varicella – 38 versus 33 percent; 83 percent of children with a history of varicella disease were immune to varicella
        </p>
        <p>
        </p>
        <p>
         The number of recorded doses was the best predictor of protective antibody [
         <a href="#rid23">
          23,24
         </a>
         ]. Protective antibody levels among adoptees without documentation of adequate immunization indicate either history of disease or undocumented receipt of vaccines.
        </p>
        <p class="headingAnchor" id="H540328914">
         <span class="h3">
          Unknown or uncertain immunization
         </span>
         <span class="headingEndMark">
          —
         </span>
         For children who do not have a valid immunization record, or whose immunization status is unknown, uncertain, or does not adhere to the United States  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ) or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fimmunizationdata.who.int%2Flisting.html%3Ftopic%3Dvaccine-schedule%26location%3D&amp;token=c1aMGh80n5JfqNiS4zUVhkGZJHzJhW7hYZJMwrVG0LFEFjNX7MxA62uBiY6p7F6hXgl8VfAnRnqUWG6LumPYIJJ9nBP597SAHqgFR7nC42s%3D&amp;TOPIC_ID=89453" target="_blank">
          WHO
         </a>
         schedules, revaccinating (as if the child were unvaccinated), serologic testing for antibodies to vaccine-preventable illnesses  (
         <a class="graphic graphic_table graphicRef87689" href="/z/d/graphic/87689.html" rel="external">
          table 3
         </a>
         ), or a combination of the two approaches is reasonable [
         <a href="#rid6">
          6,8
         </a>
         ]. The CDC Advisory Committee on Immunization Practices generally recommends age-appropriate revaccination  (
         <a class="graphic graphic_table graphicRef91329" href="/z/d/graphic/91329.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid10">
          10,26
         </a>
         ].
        </p>
        <p>
         Factors to be considered in the decision include [
         <a href="#rid27">
          27
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The age of the child (the older the child they more likely they will have immunity)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The number of doses and visits necessary for completion (taking into consideration the time and cost of visits that may not be necessary if the child is immune)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Whether the child's adjustment will be adversely affected by multiple injections and doctor visits
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The availability and cost of serologic testing
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urgency for school entry (it may take a long time to complete all necessary immunizations)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H540328921">
         <span class="h4">
          Serologic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serologic testing can be performed to evaluate whether children have protective levels of antibody from immunization or past infection for some vaccine-preventable illnesses  (
         <a class="graphic graphic_table graphicRef87689" href="/z/d/graphic/87689.html" rel="external">
          table 3
         </a>
         ). Protective levels of antibody may avoid unnecessary reimmunization. However, serologic testing is not always readily available and may be expensive [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Antibody levels do not differentiate past disease from immunization, except for hepatitis B  (
         <a class="graphic graphic_table graphicRef60827" href="/z/d/graphic/60827.html" rel="external">
          table 5
         </a>
         ). To assure long-term protection, children who have protective antibody levels and are younger than the recommended age for booster doses (eg, four to six years for diphtheria, tetanus, and pertussis) should receive the subsequent booster dose(s) at the recommended age  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ), as well as other vaccines that are initiated at a later age such as tetanus-diphtheria-acellular pertussis, the human papillomavirus series, and meningococcal vaccine.
        </p>
        <p>
         Additional caveats regarding serology for specific antigens are provided below:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diphtheria, tetanus, and hepatitis B virus
         </strong>
         – Testing for antibody to diphtheria, tetanus, and hepatitis B can be performed in children ≥5 months of age.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pertussis
         </strong>
         – Serologic testing is not widely available for pertussis. However, documented immunity to diphtheria and tetanus (ie, &gt;0.1 international unit/mL) can be used as a surrogate marker for immunity to pertussis because diphtheria, tetanus, and pertussis usually are administered in combination (eg, as diphtheria, tetanus, acellular pertussis vaccine or diphtheria, tetanus, whole cell pertussis vaccine) [
         <a href="#rid7">
          7
         </a>
         ]. However, the child's age and antibody level must be taken into consideration. As an example, acellular pertussis-containing immunization may be warranted in a two-year old who has protective but low antibody concentrations to diphtheria and tetanus (eg, &lt;0.4 international units/mL) because their immunity to pertussis is likely to wane before the four-year booster dose.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Poliovirus
         </strong>
         – Serologic testing for poliovirus is no longer recommended. Testing for antibodies to poliovirus type 2 is not available, and demonstration of antibodies to polioviruses 1 and 3 does not reliably indicate protection against poliovirus type 2 [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           H. influenzae
          </em>
         </strong>
         <strong>
          type b
         </strong>
         – Serologic testing for antibodies to Hib can also be performed in children ≥5 months. However, given that most children arrive to the United States after 12 months of age, it may be preferable to provide age-appropriate immunization for Hib rather than obtaining Hib serology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Measles, mumps, rubella, varicella, hepatitis A
         </strong>
         – Testing for antibody to measles, mumps, rubella, varicella, and hepatitis A should not be performed before 12 months of age because of the possibility of persistent maternal antibody.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Two doses of measles-mumps-rubella (MMR) vaccine are necessary if the child lacks protective levels of antibody to measles or mumps (even if they have protective levels of antibody to the other antigen and to rubella). Only one dose of MMR is necessary if the child has protective levels of antibody to measles and mumps but lacks protective levels of antibody to rubella. (See
         <a class="medical medical_review" href="/z/d/html/101273.html" rel="external">
          "Measles, mumps, and rubella immunization in infants, children, and adolescents", section on 'Catch-up immunization'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other antigens
         </strong>
         – Age-appropriate immunization with pneumococcal conjugate, rotavirus, poliovirus, and influenza vaccines is recommended. These vaccines are not routinely administered in the countries of origin, and serologic testing is not practical since the pneumococcal vaccine has at least 10 serotypes, there is no correlate of protection for rotavirus vaccine (and it should not be given if the child is &gt;8 months of age), and influenza vaccine is an annual vaccine. (See
         <a class="medical medical_review" href="/z/d/html/5960.html" rel="external">
          "Seasonal influenza in children: Prevention with vaccines", section on 'Schedule'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6023.html" rel="external">
          "Rotavirus vaccines for infants", section on 'Schedule'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6053.html" rel="external">
          "Pneumococcal vaccination in children", section on 'Routine immunization for children &lt;5 years'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H540328957">
         <span class="h4">
          Revaccinating
         </span>
         <span class="headingEndMark">
          —
         </span>
         Immunizations that are not documented or do not adhere to the United States  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ) or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fimmunizationdata.who.int%2Flisting.html%3Ftopic%3Dvaccine-schedule%26location%3D&amp;token=c1aMGh80n5JfqNiS4zUVhkGZJHzJhW7hYZJMwrVG0LFEFjNX7MxA62uBiY6p7F6hXgl8VfAnRnqUWG6LumPYIJJ9nBP597SAHqgFR7nC42s%3D&amp;TOPIC_ID=89453" target="_blank">
          WHO
         </a>
         schedules should be repeated if serologic testing is not or cannot be done. Age-appropriate immunization (or reimmunization) of internationally adopted children with unknown or uncertain immunization status as if they have received no immunizations  (
         <a class="graphic graphic_table graphicRef58271 graphicRef72079" href="/z/d/graphic/58271.html" rel="external">
          table 2A-B
         </a>
         ) is an alternative to serologic testing for diphtheria, tetanus, hepatitis A and B, measles, mumps, rubella, varicella, and Hib. Reimmunization is recommended for poliovirus and
         <em>
          Streptococcus pneumoniae
         </em>
         . Most children come to the United States outside the age range for rotavirus vaccine (&gt;8 months of age) and influenza vaccine is an annual vaccine.
        </p>
        <p>
         Repeating immunizations that have already been administered is generally considered safe. However, children younger than seven years should not receive more than six doses of diphtheria- and tetanus toxoid-containing vaccines (eg, diphtheria and tetanus toxoids [without pertussis]; diphtheria toxoid, tetanus toxoid, and acellular pertussis vaccine; diphtheria toxoid, tetanus toxoid, and whole cell pertussis vaccine) because of the risk of local and systemic reaction [
         <a href="#rid28">
          28,29
         </a>
         ]. For children being revaccinated against diphtheria, tetanus, and pertussis who develop a severe local reaction, the CDC Advisory Committee on Immunization Practices recommends serologic testing for immunoglobulin G antibody to tetanus and diphtheria toxins before administering additional doses [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H476046594">
         <span class="h1">
          IMMUNIZATIONS FOR FAMILY MEMBERS AND CONTACTS
         </span>
        </p>
        <p class="headingAnchor" id="H476046601">
         <span class="h2">
          Routine immunizations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adult and pediatric family members and close contacts of international adoptees should be current for routine immunizations  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209 graphicRef82634" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-C
         </a>
         ) before the adoptee joins the household [
         <a href="#rid9">
          9,10
         </a>
         ]. The need for immunization is highlighted by reports of vaccine-preventable diseases brought into the United States and transmitted by internationally adopted children [
         <a href="#rid2">
          2,30-40
         </a>
         ].
        </p>
        <p>
         Adult contacts of international adoptees frequently need the following vaccines before the child's arrival:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tetanus toxoid-reduced diphtheria toxoid-acellular pertussis, which serves as a tetanus booster and provides protection against pertussis (see
         <a class="medical medical_review" href="/z/d/html/3897.html" rel="external">
          "Tetanus-diphtheria toxoid vaccination in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A second measles-mumps-rubella (MMR) vaccine (if born after 1957) (see
         <a class="medical medical_review" href="/z/d/html/3893.html" rel="external">
          "Measles, mumps, and rubella immunization in adults", section on 'Who should be immunized'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13006" href="/z/d/drug information/13006.html" rel="external">
          Varicella vaccine
         </a>
         (if they have no history of varicella disease or immunization) (see
         <a class="medical medical_review" href="/z/d/html/8275.html" rel="external">
          "Vaccination for the prevention of chickenpox (primary varicella infection)", section on 'Evidence of immunity'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Influenza vaccine (see
         <a class="medical medical_review" href="/z/d/html/7007.html" rel="external">
          "Seasonal influenza vaccination in adults"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         For pediatric contacts of international adoptees whose immunizations are not current, the routine schedule may be accelerated to improve protection  (
         <a class="graphic graphic_table graphicRef58271 graphicRef72079" href="/z/d/graphic/58271.html" rel="external">
          table 2A-B
         </a>
         ). Certain vaccines can and should be given earlier than recommended in the routine schedule. For example, if a child &lt;12 months of age is traveling, one dose of MMR should be given; two additional doses will still be needed after 12 months of age. For children &gt;12 to 48 months of age, the second measles vaccine should be given early (one month after the initial vaccine) and will not need to be repeated at four to six years of age. Similarly, the second
         <a class="drug drug_pediatric" data-topicid="13006" href="/z/d/drug information/13006.html" rel="external">
          varicella vaccine
         </a>
         should be given prior to travel as well (&gt;3 months after the initial dose).
        </p>
        <p class="headingAnchor" id="H476046608">
         <span class="h2">
          Hepatitis A vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_pediatric" data-topicid="12935" href="/z/d/drug information/12935.html" rel="external">
          Hepatitis A vaccine
         </a>
         is recommended for previously unvaccinated family members and close contacts of internationally adopted children [
         <a href="#rid41">
          41,42
         </a>
         ]. In the United States, hepatitis A vaccine has been routinely recommended for children ≥12 months of age since 2006 [
         <a href="#rid42">
          42
         </a>
         ]. Children and adults born before 2006 may not have received hepatitis A vaccine.
        </p>
        <p>
         The first dose of
         <a class="drug drug_pediatric" data-topicid="12935" href="/z/d/drug information/12935.html" rel="external">
          hepatitis A vaccine
         </a>
         provides protection before the arrival of the child; a second dose, given at least six months after the first, provides long-term protection. (See
         <a class="medical medical_review" href="/z/d/html/3900.html" rel="external">
          "Hepatitis A virus infection: Treatment and prevention", section on 'Protection prior to exposure'
         </a>
         .)
        </p>
        <p>
         Hepatitis A is prevalent in resource-poor countries and can be transmitted through ingestion of contaminated food and water or feces. Outbreaks of hepatitis A associated with internationally adopted children led to the recommendations for immunization for traveling and nontraveling family members and close contacts of international adoptees children [
         <a href="#rid42">
          42
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5942.html" rel="external">
          "Overview of hepatitis A virus infection in children", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H476046615">
         <span class="h2">
          Hepatitis B vaccine
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hepatitis B vaccine is not routinely recommended for adults in the United States unless they are in a risk category (eg, health care practitioner, intravenous drug user, household contact with acute or chronic hepatitis B virus infection, etc). We suggest that family members (adults and children) of internationally adopted children be vaccinated against hepatitis B virus before the child's arrival. To allow adequate time for response, the first dose of hepatitis B vaccine should be administered at least six months before the child joins the family [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3641.html" rel="external">
          "Hepatitis B virus immunization in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101483.html" rel="external">
          "Hepatitis B virus immunization in infants, children, and adolescents", section on 'Catch-up immunization'
         </a>
         .)
        </p>
        <p>
         Unvaccinated contacts of internationally adopted children who have acute or chronic hepatitis B virus infection (ie, those who are hepatitis B surface antigen-positive) must be vaccinated promptly. Hepatitis B virus is easily transmitted to household contacts, and transmission of hepatitis B from newly adopted children to their parents has been documented [
         <a href="#rid33">
          33,35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3630.html" rel="external">
          "Epidemiology, transmission, and prevention of hepatitis B virus infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H476046622">
         <span class="h2">
          Additional immunizations for travel
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adult and pediatric family members and close contacts of international adoptees who are traveling to meet and/or accompany the international adoptee to the adoptive country should receive vaccines for travel as recommended by the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwwwnc.cdc.gov%2Ftravel%2F&amp;token=lh2yQf3FIHMiBK8aIyDxNxbSn5ZQfa1q3CZEba5RMvlUgOi72lKhSRCmQJlwqbne&amp;TOPIC_ID=89453" target="_blank">
          Centers for Disease Control and Prevention
         </a>
         . Health care providers should review the recommendations for travel immunizations several months before travel so that immunizations can be provided or updated as necessary before travel [
         <a href="#rid9">
          9
         </a>
         ]. The
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fgten.travel%2Fprep%2Fprep&amp;token=YbkZkqEohGgeXF2p2EJVieNZmnkLyG5FMDPXq4ITP5WvALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=89453" target="_blank">
          Pre-travel Providers' Rapid Evaluation Portal
         </a>
         is a clinical tool that helps health care providers prepare travelers from the United States for international travel. (See
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel"
         </a>
         .)
        </p>
        <p>
         In addition to routine immunizations (particularly measles) and hepatitis A and B vaccines, immunizations recommended before travel may include [
         <a href="#rid44">
          44
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inactivated
         <a class="drug drug_pediatric" data-topicid="12967" href="/z/d/drug information/12967.html" rel="external">
          poliovirus vaccine
         </a>
         may be recommended for adult travelers to some countries (see
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel", section on 'Poliovirus vaccine'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13020" href="/z/d/drug information/13020.html" rel="external">
          Typhoid vaccine
         </a>
         for some countries; a parenteral polysaccharide vaccine can be given for travelers ≥2 years of age and a live-attenuated oral vaccine can be given to travelers ≥6 years of age (see
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel", section on 'Typhoid vaccine'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_pediatric" data-topicid="13021" href="/z/d/drug information/13021.html" rel="external">
          Yellow fever vaccine
         </a>
         is recommended for some regions in Africa and South America (see
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel", section on 'Yellow fever vaccine'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meningococcal vaccine for certain countries in Africa and India (see
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel", section on 'Meningococcal vaccine'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Japanese encephalitis vaccine for certain travelers to Asia depending upon destination, duration, season, and activities (see
         <a class="medical medical_review" href="/z/d/html/3890.html" rel="external">
          "Immunizations for travel", section on 'Japanese encephalitis vaccine'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2162115702">
         <span class="h1">
          SARS-CoV-2 IMMUNIZATION AND TESTING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Families traveling to adopt may need to provide proof of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunization (if eligible for immunization) and a negative SARS-CoV-2 test before travel to the country of origin and/or upon return to the United States. The Centers for Disease Control and Prevention provides additional travel recommendations for
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwwwnc.cdc.gov%2Ftravel%2Fdestinations%2Flist&amp;token=GD2t7CoYRGdYUJPL1R54LDVYIBdeEa8T1ShZ3kq9xWgdNByK0GeH%2FDeJh53%2FF%2Fu9%2BTM9VZTze8IlW79l1tnlcQ%3D%3D&amp;TOPIC_ID=89453" target="_blank">
          specific destinations
         </a>
         , as does the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.usa.gov%2Fcovid-international-travel&amp;token=lFzHfu5Xyr2WkFJhkf9tP%2FibJVc60HocX7AnmhHmqjtmkPF4w2vsGqccQEPw8Kf6hTqtH8Jxyt9YIoa5fIC3iQ%3D%3D&amp;TOPIC_ID=89453" target="_blank">
          International Travel Advisory
         </a>
         .
        </p>
        <p>
         SARS-CoV-2 immunization is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/129849.html" rel="external">
          "COVID-19: Vaccines"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H476046678">
         <span class="h1">
          RESOURCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of resources that may be helpful for health care providers or parents of international adoptees are available  (
         <a class="graphic graphic_table graphicRef91058" href="/z/d/graphic/91058.html" rel="external">
          table 6
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H476048128">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunizations in the country of origin
         </strong>
         – The routine immunization schedule varies from country to country. Routine immunization schedules for specific countries are available through the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fimmunizationdata.who.int%2Flisting.html%3Ftopic%3Dvaccine-schedule%26location%3D&amp;token=c1aMGh80n5JfqNiS4zUVhkGZJHzJhW7hYZJMwrVG0LFEFjNX7MxA62uBiY6p7F6hXgl8VfAnRnqUWG6LumPYIJJ9nBP597SAHqgFR7nC42s%3D&amp;TOPIC_ID=89453" target="_blank">
          World Health Organization
         </a>
         (WHO). Internationally adopted children typically have had the opportunity to receive Bacillus Calmette-Guérin, diphtheria, tetanus, pertussis, poliovirus, hepatitis B virus, and measles (with or without mumps and rubella) vaccines before adoption. (See
         <a class="local">
          'Immunizations in the country of origin'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunization after adoption
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Internationally adopted children should be immunized according to the United States' recommended schedule for healthy infants, children, and adolescents  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ). Immunization must be initiated within 30 days of arrival (if not before). (See
         <a class="local">
          'Immunization after adoption'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The approach to immunizing internationally adopted children depends upon the availability and quality of documentation of immunizations from the home country. (See
         <a class="local">
          'Immunization after adoption'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Written records may be considered valid if the vaccines, dates of administration, numbers of doses, intervals between doses, and age of the patient at the time of immunization are comparable to the United States  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-B
         </a>
         ) or
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fimmunizationdata.who.int%2Flisting.html%3Ftopic%3Dvaccine-schedule%26location%3D&amp;token=c1aMGh80n5JfqNiS4zUVhkGZJHzJhW7hYZJMwrVG0LFEFjNX7MxA62uBiY6p7F6hXgl8VfAnRnqUWG6LumPYIJJ9nBP597SAHqgFR7nC42s%3D&amp;TOPIC_ID=89453" target="_blank">
          WHO
         </a>
         schedules.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For poliovirus immunization, this requires immunization with trivalent inactivated
         <a class="drug drug_pediatric" data-topicid="12967" href="/z/d/drug information/12967.html" rel="external">
          poliovirus vaccine
         </a>
         or trivalent oral poliovirus vaccine.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         For hepatitis A immunization, this requires immunization with a vaccine other than Aimmugen or Twinrix Jr [
         <a href="#rid10">
          10
         </a>
         ]. Twinrix Jr is a combination hepatitis A/hepatitis B vaccine; the hepatitis B component can be counted as valid, but not the hepatitis A component.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Children who have an adequate written documentation of immunization but whose immunizations are not up-to-date should receive age-appropriate catch-up immunizations  (
         <a class="graphic graphic_table graphicRef58271 graphicRef72079" href="/z/d/graphic/58271.html" rel="external">
          table 2A-B
         </a>
         ). (See
         <a class="local">
          'Valid immunization record'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For children whose immunization status is unknown or uncertain, serologic testing for antibodies to vaccine-preventable illnesses  (
         <a class="graphic graphic_table graphicRef87689" href="/z/d/graphic/87689.html" rel="external">
          table 3
         </a>
         ), revaccinating (as if the child were unvaccinated), or a combination of the two approaches may be undertaken. (See
         <a class="local">
          'Unknown or uncertain immunization'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunizations for family members and contacts
         </strong>
         – Adult and pediatric family members and close contacts of international adoptees should be up-to-date with routine immunizations before the adoptee joins the household  (
         <a class="graphic graphic_figure graphicRef82617 graphicRef58209 graphicRef82634" href="/z/d/graphic/82617.html" rel="external">
          figure 1A-C
         </a>
         ). Previously unvaccinated family members and close contacts also should receive hepatitis A and hepatitis B vaccines before the arrival of the adoptee. (See
         <a class="local">
          'Routine immunizations'
         </a>
         above and
         <a class="local">
          'Hepatitis A vaccine'
         </a>
         above and
         <a class="local">
          'Hepatitis B vaccine'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Adult and pediatric family members and close contacts of international adoptees who are traveling to meet and/or accompany the international adoptee to the adoptive country should receive vaccines for travel as recommended by the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwwwnc.cdc.gov%2Ftravel%2F&amp;token=lh2yQf3FIHMiBK8aIyDxNxbSn5ZQfa1q3CZEba5RMvlUgOi72lKhSRCmQJlwqbne&amp;TOPIC_ID=89453" target="_blank">
          Centers for Disease Control and Prevention
         </a>
         . (See
         <a class="local">
          'Additional immunizations for travel'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          WHO vaccine-preventable diseases: monitoring system. 2016 global summary. http://apps.who.int/immunization_monitoring/globalsummary (Accessed on March 22, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Su Q, Zhang Y, Ma Y, et al. Measles imported to the United States by children adopted from China. Pediatrics 2015; 135:e1032.
          </a>
         </li>
         <li class="breakAll">
          Department of Health and Human Services. Criteria for Vaccination Requirements for U.S. Immigration Purposes. http://www.gpo.gov/fdsys/pkg/FR-2009-11-13/pdf/E9-27317.pdf (Accessed on May 21, 2013).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Notice of revised vacination criteria for U.S. immigration http://www.cdc.gov/immigrantrefugeehealth/laws-regs/vaccination-immigration/revised-vaccination-criteria-immigration.html (Accessed on May 21, 2013).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verla-Tebit E, Zhu X, Holsinger E, Mandalakas AM. Predictive value of immunization records and risk factors for immunization failure in internationally adopted children. Arch Pediatr Adolesc Med 2009; 163:473.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Children who received immunizations outside the United States or whose immunization status is unknown or uncertain. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.96.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eckerle JK, Howard CR, John CC. Infections in internationally adopted children. Pediatr Clin North Am 2013; 60:487.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Medical Examination of Immigrants and Refugees. www.cdc.gov/immigrantrefugeehealth/exams/medical-examination.html (Accessed on March 22, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:817.
          </a>
         </li>
         <li class="breakAll">
          Kroger A, Bahta L, Hunter P. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Special situations. Persons vaccinated outside the United States. Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/special-situations.html (Accessed on September 28, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marin M, Patel M, Oberste S, Pallansch MA. Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States. MMWR Morb Mortal Wkly Rep 2017; 66:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdulla RY, Rice MA, Donauer S, et al. Hepatitis A in internationally adopted children: screening for acute and previous infections. Pediatrics 2010; 126:e1039.
          </a>
         </li>
         <li class="breakAll">
          Staat MA, Rice M, Leach K, Rawlings A. Medical Conditions in Internationally Adopted Children from Africa [abstract]. Pediatric Academy Societies Annual Meeting: Boston Massachusetts, 2012.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saiman L, Aronson J, Zhou J, et al. Prevalence of infectious diseases among internationally adopted children. Pediatrics 2001; 108:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hostetter MK, Johnson DE. Immunization status of adoptees from China, Russia, and Eastern Europe. Pediatr Res 1998; 43:147A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller LC. Internationally adopted children--immunization status. Pediatrics 1999; 103:1078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller LC, Comfort K, Kely N. Immunization status of internationally adopted children. Pediatrics 2001; 108:1050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schulpen TW, van Seventer AH, Rümke HC, van Loon AM. Immunisation status of children adopted from China. Lancet 2001; 358:2131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viviano E, Cataldo F, Accomando S, et al. Immunization status of internationally adopted children in Italy. Vaccine 2006; 24:4138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cilleruelo MJ, de Ory F, Ruiz-Contreras J, et al. Internationally adopted children: what vaccines should they receive? Vaccine 2008; 26:5784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Schaik R, Wolfs TF, Geelen SP. Improved general health of international adoptees, but immunization status still insufficient. Eur J Pediatr 2009; 168:1101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Staat MA, Stadler LP, Donauer S, et al. Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases. Vaccine 2010; 28:7947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stadler LP, Donauer S, Rice M, et al. Factors associated with protective antibody levels to vaccine preventable diseases in internationally adopted children. Vaccine 2010; 29:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tchidjou HK, Gargiullo L, Vescio F, et al. Immunization status of internationally adopted children in Rome, Italy. Niger J Clin Pract 2015; 18:307.
          </a>
         </li>
         <li class="breakAll">
          Kroger A, Bahta L, Hunter P. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP). Timing and spacing of immunobiologics. Unknown or uncertain vaccination status. Available at: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html (Accessed on September 28, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnett ED. Immunizations and infectious disease screening for internationally adopted children. Pediatr Clin North Am 2005; 52:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rennels MB, Deloria MA, Pichichero ME, et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 2000; 105:e12.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Pertussis (whooping cough). In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.578.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson ME, Kimble J. Posttravel hepatitis A: probable acquisition from an asymptomatic adopted child. Clin Infect Dis 2001; 33:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer GE, Teshale EH, Miller C, et al. Hepatitis A among international adoptees and their contacts. Clin Infect Dis 2008; 47:812.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sweet K, Sutherland W, Ehresmann K, Lynfield R. Hepatitis A infection in recent international adoptees and their contacts in Minnesota, 2007-2009. Pediatrics 2011; 128:e333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hershow RC, Hadler SC, Kane MA. Adoption of children from countries with endemic hepatitis B: transmission risks and medical issues. Pediatr Infect Dis J 1987; 6:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friede A, Harris JR, Kobayashi JM, et al. Transmission of hepatitis B virus from adopted Asian children to their American families. Am J Public Health 1988; 78:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sokal EM, Van Collie O, Buts JP. Horizontal transmission of hepatitis B from children to adoptive parents. Arch Dis Child 1995; 72:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Pertussis in an infant adopted from Russia--May 2002. MMWR Morb Mortal Wkly Rep 2002; 51:394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Measles outbreak among internationally adopted children arriving in the United States, February-March 2001. MMWR Morb Mortal Wkly Rep 2002; 51:1115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Update: Multistate investigation of measles among adoptees from China--April 16, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Measles among adults associated with adoption of children in China--California, Missouri, and Washington, July-August 2006. MMWR Morb Mortal Wkly Rep 2007; 56:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyangoma EN, Olson CK, Benoit SR, et al. Measles outbreak associated with adopted children from China--Missouri, Minnesota, and Washington, July 2013. MMWR Morb Mortal Wkly Rep 2014; 63:301.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Hepatitis A. In: CDC Yellow Book 2020: Health Information for International Travel. Available at http://wwwnc.cdc.gov/travel/page/yellowbook-home (Accessed on August 07, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020; 69:1.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Hepatitis B. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.381.
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. The pretravel consultation. In: CDC Yellow Book 2020: Health Information for International Travel. Available at: http://wwwnc.cdc.gov/travel/page/yellowbook-home (Accessed on August 07, 2019).
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 89453 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="http://apps.who.int/immunization_monitoring/globalsummary" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : WHO vaccine-preventable diseases: monitoring system. 2016 global summary. http://apps.who.int/immunization_monitoring/globalsummary (Accessed on March 22, 2018).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25733758" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Measles imported to the United States by children adopted from China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25733758" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Measles imported to the United States by children adopted from China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25733758" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Measles imported to the United States by children adopted from China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19414695" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Predictive value of immunization records and risk factors for immunization failure in internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19414695" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Predictive value of immunization records and risk factors for immunization failure in internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23481113" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Infections in internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23481113" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Infections in internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19659433" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19659433" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23760231" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28081056" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20937651" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hepatitis A in internationally adopted children: screening for acute and previous infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20937651" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Hepatitis A in internationally adopted children: screening for acute and previous infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11533325" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Prevalence of infectious diseases among internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Immunization status of adoptees from China, Russia, and Eastern Europe
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10357648" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Internationally adopted children--immunization status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11589214" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Immunization status of internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11784632" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Immunisation status of children adopted from China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16545505" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Immunization status of internationally adopted children in Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18786590" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Internationally adopted children: what vaccines should they receive?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19125292" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Improved general health of international adoptees, but immunization status still insufficient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20937322" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Serologic testing to verify the immune status of internationally adopted children against vaccine preventable diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21036132" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Factors associated with protective antibody levels to vaccine preventable diseases in internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25772909" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Immunization status of internationally adopted children in Rome, Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25772909" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Immunization status of internationally adopted children in Rome, Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16154464" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Immunizations and infectious disease screening for internationally adopted children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10617749" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10617749" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11528585" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Posttravel hepatitis A: probable acquisition from an asymptomatic adopted child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18684098" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Hepatitis A among international adoptees and their contacts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21727107" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Hepatitis A infection in recent international adoptees and their contacts in Minnesota, 2007-2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3299233" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Adoption of children from countries with endemic hepatitis B: transmission risks and medical issues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3337301" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Transmission of hepatitis B virus from adopted Asian children to their American families.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7702394" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Horizontal transmission of hepatitis B from children to adoptive parents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12018796" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Pertussis in an infant adopted from Russia--May 2002.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12530709" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Measles outbreak among internationally adopted children arriving in the United States, February-March 2001.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15103298" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Update: Multistate investigation of measles among adoptees from China--April 16, 2004.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17318114" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Measles among adults associated with adoption of children in China--California, Missouri, and Washington, July-August 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24717816" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Measles outbreak associated with adopted children from China--Missouri, Minnesota, and Washington, July 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24717816" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Measles outbreak associated with adopted children from China--Missouri, Minnesota, and Washington, July 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32614811" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
